Bio-Rad Laboratories price to free cash flow BIO

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 28.0×
10-year median: 39.9×
Against its 10-year history: 20th; percentile: 0 is its lowest day, 100 its highest
10-year range: 16.8× to 184×
Peer median: 26.4×

Bio-Rad Laboratories' price to free cash flow is 28.0× as of Oct 23, 2026.

That is below its ten-year median of 39.9×, lower than on 80% of days in the last ten years.

Over that time it ranged from 16.8× in Jun 2025 to 184× in Mar 2023.

The median for 10 diagnostics and research stocks of a similar size is 26.4×.

Price to free cash flow over time

median 39.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	28.0×	18.5×	29.4×
2025	24.3×	16.8×	40.9×
2024	37.5×	36.1×	54.4×
2023	42.0×	37.4×	184×
2022	82.8×	26.3×	85.8×
2021	33.9×	32.6×	53.5×
2020	47.1×	26.8×	54.0×
2019	40.5×	38.7×	61.9×
2018	n/m a value too high to mean anything
2017	86.0×	77.8×	173×
2016	163×	52.2×	164×
2015	61.3×	16.9×	62.6×
2014	17.9×	16.3×	59.0×
2013	46.2×	26.5×	48.0×
2012	26.7×	11.1×	30.2×
2011	11.0×	8.3×	11.6×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.

Company	Price to free cash flow
BIOBio-Rad Laboratories	28.0×
CAICaris Life Sciences	73.0×
LNTHLantheus	16.8×
RVTYRevvity	31.7×
MEDPMedpace	26.4×
BLLNBillionToOne	153×
VCYTVeracyte	23.2×
LHLabcorp	23.1×
DGXQuest Diagnostics	19.8×
CDNACareDx	n/m
MTDMettler-Toledo International	38.7×
Peer median	26.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Bio-Rad Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.